Genetic profiling of late radiation toxicity in patients with prostate cancer

Genetic profiling of late radiation toxicity in patients with prostate cancer - repeat Svensson-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35092

Enrollment

Registered

2010-03-02

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer side-effects

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adult males at leats 2 years after curative radiotherapy for prostate cancer no evidence of prostate cancer two groups are selected: with severe toxicity (SOMA grade 3-4), or with no or mild toxicity (grade 0-1)

Exclusion criteria

Exclusion criteria: - patients who had prostatectomy or brachytherapy - patients with severe mental or somatic disorders

Design outcomes

Primary

Measure	Time frame
- gene expression profile in lymphocytes - toxicity questionnaire	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results